Following President Trump’s meeting with pharmaceutical executives this month, many foreign drug makers have begun planning production sites in the United States. Aurobindo Pharma, an Indian pharmaceutical company is one of these foreign drug makers interested in...
The same day congressional voiced aired concern over Marathon’s $89,000 price of a decades-old Duchenne Muscular Disorder treatment, EMFLAZA (deflazacort), Marathon’s CEO released a statement Monday citing that the company is pausing their “commercialization efforts.”...
In 2015, Incyte and Agenus both agreed to work on developing and commercializing antibodies GITR and GX40. In a statement early this week, however, the two have announced plans for Incyte to retain rights to solely develop and commercialize the drugs, profits from...
Executive Leadership Support Forum: Raleigh-Durham: Speaker Interview Cynthia Harris Virtual Executive Assistant CHarrisVirtual Assistant Cynthia has been an assistant since 1981, supporting senior leaders in industries such as: university, banking, corporate and...
Robert L. Gershon Chief Executive Officer BOVIE MEDICAL Robert L. Gershon, CEO and Director of Bovie Medical Corporation, has over 28 years of healthcare industry experience. Under his leadership Bovie Medical has increased its market cap from $37M to $150M. On...
